VeChain, a blockchain-powered supply chain platform, has announced a partnership with Chinese olive oil brand Olive Times to ensure the authenticity and traceability of its premium products. The collaboration will utilize VeChain's Blockchain-as-a-Service (BaaS) platform to track the production line of Olive Times' ultra-premium extra virgin olive oil, dubbed "Special-Olive."
The initiative aims to log key production data—including crushing and extraction processes, quality certification, and acidity levels—onto the VeChainThor blockchain. This provides consumers with immutable, transparent proof that the product meets its promised quality standards. Olive Times CEO Jane Gong stated the platform allows the company to share product information "in a trustless and immutable manner," offering customers a real-time, trustworthy view into operations.
This partnership taps into a growing Chinese market for organic olive oil, where annual consumption is estimated by the International Olive Council at 66,000 tonnes. Yvette Xia, Chief Marketing Officer at Olive Times, highlighted the strategic value, noting that "using blockchain technology to turbocharge your marketing strategy is a new and effective method of brand-building."
The Olive Times deal follows another recent VeChain integration with Oatman Farms Premium Provisions in Arizona. The family-owned farm uses the Producers Market StoryBird application, powered by the VeChain Toolchain, to transparently share its farming practices and product origins with consumers. This trend of supply chain adoption coincides with a positive performance for the VeChain token (VET), which was trading at $0.1288, up 3.66% in 24 hours at the time of the report.
Separately, analysis of VeChain's growth catalysts points to its recent technological upgrades and expanding use cases. The activation of the VeChainThor version 1.5 hard fork (ETH_IST) ensured compatibility with the latest Ethereum Virtual Machine, while the PoA 2.0 Testnet demonstrated a capacity for 21.6 million daily transactions. Furthermore, a partnership with DNV enabled Renji Hospital in China to launch a blockchain-enabled IVF service app, "MyBaby," targeting a Chinese IVF market projected to surpass $2.8 billion by 2025.
